Home

EORTC 2011

Data from five studies of cabozantinib were presented at the 2011 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics. The conference was held in San Francisco, November 12th – 16th, 2011.

  • About Us
    • Management
    • Board of Directors
    • Collaborations
    • Locations
    • Contact Us
  • COMETRIQ™
  • Pipeline
    • GDC-0973 (XL518)
    • Partnered Compounds
  • Clinical Trials
    • Exelixis Clinical Trials
    • National Cancer Institute Sponsored Trials
    • Investigator Sponsored Trials
    • FAQs about Clinical Trials
  • Medical Information
  • Investors & Media
    • Management and Board
    • Corporate Governance
    • Stock Information
    • Analyst Coverage
    • Earnings Estimates
    • Earnings Ratings
    • Annual Reports
    • SEC Filings
    • Press Releases
    • Event Calendar
    • Media Resources
    • Information Request
    • Investor FAQs
    • Contact IR
  • Careers
    • Job Opportunities
© Exelixis, Inc. 2013   Website design: Hane Chow, Inc.
  • Privacy
  • Terms of Use